Tavaborole Completed Phase 2 Trials for Onychomycosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00680160Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I)
NCT00679601Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)
NCT00680134Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With Onychomycosis